162 related articles for article (PubMed ID: 4394344)
1. Increased plasma renin activity induced in rats by physostigmine and effects of alpha- and beta-receptors blocking drugs thereon.
Alexandre JM; Menard J; Chevillard C; Schmitt H
Eur J Pharmacol; 1970 Sep; 12(1):127-31. PubMed ID: 4394344
[No Abstract] [Full Text] [Related]
2. Pressor effect of beta blocking agents in rats.
Regoli D; Regoli U; Gysling E
Can J Physiol Pharmacol; 1972 Mar; 50(3):207-14. PubMed ID: 4402339
[No Abstract] [Full Text] [Related]
3. Cardiac catecholamine levels and blood pressure after chronic treatment with beta-adrenergic blocking agents.
Mazurkiewicz-Kwilecki IM; Romagnoli A
J Pharm Pharmacol; 1970 Mar; 22(3):235-7. PubMed ID: 4399498
[No Abstract] [Full Text] [Related]
4. Effect of two new beta-blocking drugs on heart rate and blood pressure during passive tilting in man.
Fuccella LM; Reban J; Bassini F; Lattes E; Mandelli V
Eur J Clin Pharmacol; 1971 Dec; 4(1):12-7. PubMed ID: 4402874
[No Abstract] [Full Text] [Related]
5. Effect of some -adrenergic blocking agents on the acetylcholine content of heart. An experimental study in mice.
Khanna NK
Eur J Pharmacol; 1972 Feb; 17(2):309-11. PubMed ID: 4402099
[No Abstract] [Full Text] [Related]
6. Beta-adrenergic blocking activity and haemodynamic effects in man of Kö 1313, a new beta-adrenergic antagonist.
Gilfrich HJ; Rahn KH; Nicolescu RF
Eur J Clin Pharmacol; 1971 Sep; 3(4):204-8. PubMed ID: 4402827
[No Abstract] [Full Text] [Related]
7. Cardiac toxicity of -lytic drugs.
Roba J
Arch Int Pharmacodyn Ther; 1972 Apr; 196():Suppl 196:120-. PubMed ID: 4403294
[No Abstract] [Full Text] [Related]
8. Salivation in mice as an index of adrenergic activity. I. Salivation and temperature responses to d-amphetamine and other sialogogues and the effects of adrenergic blocking agents.
Maling HM; Williams MA; Koppanyi T
Arch Int Pharmacodyn Ther; 1972 Oct; 199(2):318-32. PubMed ID: 4403618
[No Abstract] [Full Text] [Related]
9. [Pindolol. New beta blocking agent. Effect on cardiac chronotropism and ionotropism and comparison of its activity with propranolol].
Aquaro G; Baduini G; Pavia M; Poletti T
Minerva Cardioangiol; 1972 Jun; 20(6):324-9. PubMed ID: 4402731
[No Abstract] [Full Text] [Related]
10. [Efficiency of myocardial performance and oxidation of exogenous 14C-substrates under the influence of beta-receptor stimulating and blocking agents, as compared with other cardioactive drugs].
Range H; Bischoff M; Siess M
Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):432-3. PubMed ID: 4397506
[No Abstract] [Full Text] [Related]
11. [Studies on cardiovascular drugs. VII. Adrenergic -receptor blocking activities of 1-tert-butylamino-3-(o-(tetrahydrofururyloxy)-phenoxy)-2-propanol hydrochloride (Y-6124)].
Nakanishi M; Imamura H; Nakamura T; Kimura T
Yakugaku Zasshi; 1972 Apr; 92(4):375-83. PubMed ID: 4403075
[No Abstract] [Full Text] [Related]
12. Comparison of beta-adrenergic blocking activity of DCI, H56-28, ICI50172, LB46, methoxamine, MJ1999 and propranolol in the blood perfused canine papillary muscle preparation.
Hashimoto K; Endoh M; Tamura K; Taira N
Experientia; 1970; 26(7):757-9. PubMed ID: 4393455
[No Abstract] [Full Text] [Related]
13. Comparison of beta-adrenergic blocking effect of DCI, methoxamine, propranolol, MJ 1999, H 56-28, LB 46 and I.C.I. 50 172 on the chronotropic response to isoprenaline.
Okuda K; Chiba S; Taira N; Hashimoto K
Jpn J Pharmacol; 1970 Jun; 20(2):294-304. PubMed ID: 4393949
[No Abstract] [Full Text] [Related]
14. Beta-adrenergic receptors in coronary and skeletal muscle arteries.
Baron GD; Speden RN; Bohr DF
Am J Physiol; 1972 Oct; 223(4):878-81. PubMed ID: 4403874
[No Abstract] [Full Text] [Related]
15. Effects of beta-adrenoceptor blocking drugs on the chronotropic and inotropic actions of isoprenaline on the acutely denervated dog heart.
Harry JD; Kappagoda CT; Linden RJ; Snow HM
Br J Pharmacol; 1971 Feb; 41(2):387P-389P. PubMed ID: 4396704
[No Abstract] [Full Text] [Related]
16. Pressor action of beta blocking agents in rats.
Regoli D
Can J Physiol Pharmacol; 1970 Jul; 48(7):481-9. PubMed ID: 5430353
[No Abstract] [Full Text] [Related]
17. The effect of LB-46, a new beta adrenergic blocking agent, on pulse and blood pressure at rest and after exercise in healthy volunteers.
Mehta AB; Cooverji ND; Agrawal AB; Shah AC; Patnekar PN; Vora DD
J Assoc Physicians India; 1971 Nov; 19(11):765-70. PubMed ID: 4399862
[No Abstract] [Full Text] [Related]
18. [Comparative studies on the effect of 2 beta receptor blockaders on elevated blood pressure and kidney function].
Anlauf M; Heimsoth V; Ulrych M; Bock KD
Verh Dtsch Ges Inn Med; 1969; 75():169-72. PubMed ID: 4395389
[No Abstract] [Full Text] [Related]
19. Plasma renin activity in hyper- and hypothyroidism: effect of adrenergic blocking agents.
Hauger-Klevene JH; Brown H; Zavaleta J
J Clin Endocrinol Metab; 1972 Apr; 34(4):625-9. PubMed ID: 4401157
[No Abstract] [Full Text] [Related]
20. Studies on adrenaline-induced leucocytosis in normal man. II. The effects of and adrenergic blocking agents.
French EB; Steel CM; Aitchison WR
Br J Haematol; 1971 Oct; 21(4):423-8. PubMed ID: 4399331
[No Abstract] [Full Text] [Related]
[Next] [New Search]
